NPPB and stroke disorder: Protein biomarkers of stroke risk might guide decisions on primary stroke prevention and have been shown to inform on stroke risk beyond clinical scales in secondary analyses of RCT data (e.g. NT-proBNP beyond the CHA2DS2VASc score69).